15,459
Participants
Start Date
March 27, 2009
Primary Completion Date
March 1, 2011
Study Completion Date
January 31, 2014
Malaria Vaccine 257049
administered intramuscularly into the left deltoid.
Meningococcal C Conjugate Vaccine
administered intramuscularly into the left deltoid.
Cell-culture rabies vaccine
administered intramuscularly into the left deltoid.
TritanrixHepB/Hib
administered intramuscularly into the left deltoid.
Polio Sabin Oral Polio Vaccine (GSK)
administered orally.
GSK Investigational Site, Kilifi
GSK Investigational Site, Ouagadougou
GSK Investigational Site, Lambaréné
GSK Investigational Site, Kintampo
GSK Investigational Site, Kumasi
GSK Investigational Site, Kisumu
GSK Investigational Site, Lilongwe
GSK Investigational Site, Maputo
GSK Investigational Site, Dar es Salaam
GSK Investigational Site, Tanga
Lead Sponsor
The PATH Malaria Vaccine Initiative (MVI)
OTHER
GlaxoSmithKline
INDUSTRY